跳至主要内容
临床试验/NCT04043273
NCT04043273已完成不适用

Treatment-related Benefit and Satisfaction in Fabry Patients. Insight in Patients Expectations and Preferences (SATIS-Fab)

Amicus Therapeutics France SAS15 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2019年4月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
69
试验地点
15
主要终点
Treatment benefit, derived from Patients Benefit Index (PBI), in relation to patients needs and expectations towards their specific treatment.

研究概览

简要总结

In the shared decision-making process, patients should express their expectations and preferences regarding treatment to the physician. A specific questionnaire addressing needs and expectations of Fabry patients has been built at the initiative of Amicus. In addition, this questionnaire also evaluates the benefit of treatment from the patient's perspective. Nothing is known until now on patient's expectations, potential clustering of patients regarding their expectations and evaluation of treatment benefit from the patients perspective.

Study objectives are differentiated according to the study phase (inclusion and follow-up). At inclusion, the primary objective is to cluster patients according to their needs and expectations regarding treatment. During follow-up, the primary objective is to evaluate treatment benefit in relation with patients needs and expectations.

详细描述

Prospective, longitudinal, non-comparative, open-label, multicentre, non interventional cohort study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients ≥ 16 years old
  • Diagnosed with Fabry disease
  • With amenable mutation
  • Decision by clinician to start or pursue ongoing ERT or migalastat
  • Non-opposition form to participate in the study signed

排除标准

  • Concomitant patient participation in an interventional clinical study (Category 1 interventional research or category 2 interventional research according to the Jardé law classification in France)

结局指标

主要结局

Treatment benefit, derived from Patients Benefit Index (PBI), in relation to patients needs and expectations towards their specific treatment.

时间窗: 12 month

Patients Benefit Index (PBI): descriptive statistics. The PBI will be calculated by reference to the PNQ measured at the preceding visit The proportion of patients with PBI ≥ 1 will be described with a two-sided 95% confidence interval.

Homogeneous clusters of patients according to their needs and expectations towards the treatment received.

时间窗: Baseline

Number of clusters will be defined using a non-supervised classification method.

次要结局

未报告次要终点

研究者

发起方
Amicus Therapeutics France SAS
申办方类型
Industry
责任方
Sponsor

研究点 (15)

Loading locations...

相似试验

Treatment-related Benefit and Satisfaction in Fabry... | 临床试验